Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical cromoglicate solution in mastocytosis (phase II exploratory)
2011-006275-20Phase 2Terminated
- Sponsor
- LEO Pharma
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in mastocytosis and Diffuse cutaneous mastocytosis (DCM) comparing Topical cromoglicate solution 20 mg/ml with Topical solution vehicle (placebo) (2 arms). Primary endpoint: Clinical evaluation of treatment response (Darier’s sign composite score and VAS). Started Jun 2012; status: terminated.
02
Drugs
sodium cromoglicate
03
Conditions
mastocytosisDiffuse cutaneous mastocytosis (DCM)
Beyond the preview
Go deeper on 2011-006275-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006275-20.